The results showed that exposure to BPA after children were born was associated with a significant improved threat of wheeze and asthma. What’s more, this improved risk for wheeze and asthma was noticed at ‘fairly routine, low doses of exposure to BPA,’ Dr. Donohue stated. Incredibly, a large proportion – – more than 90 % – – of the children in the study had detectable levels of BPA metabolite in their bodies, a locating echoed in earlier research. Of course, this does not mean that all children with BPA exposure will develop asthma. ‘Just as smoking escalates the risk of lung cancer however, not everyone who smokes gets lung malignancy, not every young child exposed to BPA will develop asthma,’ Dr.We continue to believe that pixantrone should be considered as cure option for individuals with relapsed/refractory intense NHL. Bianco, M.D., CEO of CTI. We are focused on working carefully with the FDA to handle the committee’s responses as quickly as we are able to. SOURCE Cell Therapeutics, Inc.. Bayer Collaboration Could Net $540M+ For Compugen Bayer HealthCare will synergy with Compugen on preclinical study toward antibody-based cancers immunotherapies against two potential immune checkpoint targets discovered by Compugen, with Bayer working out complete control over further advancement and keeping worldwide commercialization privileges for any resulting tumor therapeutics.